Literature DB >> 4912802

Antifibrinolytic therapy with Cyklokapron in connection with prostatectomy. A double blind study.

P O Hedlund.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 4912802     DOI: 10.3109/00365596909135401

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


× No keyword cloud information.
  15 in total

Review 1.  What is the evidence for using hemostatic agents in surgery?

Authors:  Brian L Erstad
Journal:  Eur Spine J       Date:  2004-05-07       Impact factor: 3.134

2.  Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers.

Authors:  O Eriksson; H Kjellman; A Pilbrant; M Schannong
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

Review 3.  Clinical pharmacology of aminocaproic and tranexamic acids.

Authors:  I M Nilsson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

4.  Antifibrinolytic therapy in genitourinary tract surgery.

Authors:  L Andersson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

Review 5.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 6.  Tranexamic acid: a review of its use in surgery and other indications.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

7.  The effects of low-dose heparin treatment on patients undergoing transvesical prostatectomy.

Authors:  P O Hedlund; M Blombäck
Journal:  Urol Res       Date:  1981

8.  Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.

Authors:  L Andersson; O Eriksson; P O Hedlund; H Kjellman; B Lindqvist
Journal:  Urol Res       Date:  1978

9.  Antifibrinolytic therapy for prevention of hemorrhage during surgery of the thyroid gland.

Authors:  O Auvinen; G A Baer; I Nordback; J Saaristo
Journal:  Klin Wochenschr       Date:  1987-03-16

10.  Pharmacokinetics and bioavailability of tranexamic acid.

Authors:  A Pilbrant; M Schannong; J Vessman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.